Maverick Investing

NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)
Sep29

NRx Pharmaceuticals Announces Improved Survival at One Year in Highly Comorbid COVID-19 Patients Treated with ZYESAMI (aviptadil)

   ZYESAMI™ (aviptadil) Has Previously Demonstrated a Statistically Significant Increase in Survival of Highly Comorbid COVID-19 Patients in Two 60-day Trials – In a Study of Highly Comorbid Patients, ZYESAMI Provided a Threefold, Statistically Significant Increase in Likelihood of Survival at One Year RADNOR, Pa., Sept. 27, 2021 /PRNewswire/ — NRx Pharmaceuticals (Nasdaq: NRXP), a clinical stage, biopharmaceutical...

Read More
$BACON Coin — Fractionalizing Home Loans on the Blockchain with Karl Jacob of LoanSnap
Sep29

$BACON Coin — Fractionalizing Home Loans on the Blockchain with Karl Jacob of LoanSnap

  About the episode On this episode, Kevin talks to LoanSnap co-founder and CEO Karl Jacob about how consumers can invest in and receive yields formerly reserved by big banks and governments. They also discuss the tokenization of commercial real estate, how neighbors can pitch in to fractionalize and purchase foreclosed homes, why traditional 30-year mortgages are going away, and how renting might turn into fractional ownership...

Read More
List Of 10 Most Expensive NFTs Ever Sold
Sep01

List Of 10 Most Expensive NFTs Ever Sold

The following will list the top 10 most expensive NFTs on the market and help you understand why these NFTs are valuables. The crypto community is more than eager to invest in NFTs such as unique digital assets, songs, images, collectibles, GIFs, or Memes. More so, they are voraciously buying various non-fungible tokens creating a new form of digital assets industry from the last few months. Well, just in February, there are more than...

Read More
NRx Pharmaceuticals Announces Emergency Use Authorization Of ZYESAMI In Nation Of Georgia
Jul28

NRx Pharmaceuticals Announces Emergency Use Authorization Of ZYESAMI In Nation Of Georgia

NRx Pharmaceuticals (NASDAQ:NRXP) (NRx), a clinical stage, global biopharmaceutical company, today announced that the Nation of Georgia’s Prime Minister and Minister of Health have issued an Emergency Use Authorization for intravenous ZYESAMI™ (aviptadil) for the treatment of Critical COVID-19.   NRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia “Lead investigators...

Read More
NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI, Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval
Jul22

NRx Pharmaceuticals Announces First Successful Commercial Formulation for ZYESAMI, Enabling Volume Manufacture, Shipping, and Stockpiling of COVID-19 Medication Subject to Regulatory Approval

NRx Pharmaceuticals (NRx) (NASDAQ:NRXP) announced today it has validated the first commercial formulation of ZYESAMI™ (aviptadil) for intravenous use, allowing for high volume manufacture, with an anticipated one year or greater stability, under appropriate storage conditions. Simultaneously, NRx has achieved a 30-to-50-fold increase in its manufactured lot size of aviptadil, with a concurrent 90% reduction in the cost of its peptide...

Read More
Top 10 Cryptocurrencies
Apr26

Top 10 Cryptocurrencies

The top 10 cryptocurrencies analysis articles aim to provide you with the most comprehensive but not overloaded picture of the cryptocurrency market. The top 10 cryptocurrencies price news and changes are researched by professional traders and investors, giving you the opportunity to have a perfect ground for making your own investment choices. Cointelegraph’s cryptocurrencies analysis is the most efficient and swift way to keep...

Read More
XRP Price Analysis: XRP Continues To Fall As Price is Stuck In Descending Channel
Apr26

XRP Price Analysis: XRP Continues To Fall As Price is Stuck In Descending Channel

XRP has been downtrending for over a week Price has been held by $1.03 support Indicators show a breakout is soon XRP rose 300% since the start of April. After being stuck under 1$ for nearly 3 years, thanks to the SEC lawsuit, XRP managed to breakout and set a three year high. This bullish impulse was not held up well as BTC started downtrending a few days after XRP hit its high of $1.95. XRP needs to break above its price channel to...

Read More
Bitcoin Price Consolidates Near $50K, Why BTC Bulls Could Fail Near $52.5K
Apr26

Bitcoin Price Consolidates Near $50K, Why BTC Bulls Could Fail Near $52.5K

Bitcoin price extended its decline below the $50,000 support against the US Dollar. BTC is now consolidating losses and it remains at a risk of more downside below $48,000. Bitcoin declined heavily below the $52,000 and $50,000 support levels. The price is now trading well below $52,000 and the 100 simple moving average (4-hours). There is a key bearish trend line forming with resistance near $52,800 on the 4-hours chart of the...

Read More
THE GREATEST MONEY REVOLUTION OF ALL TIME
Apr22

THE GREATEST MONEY REVOLUTION OF ALL TIME

Starting in 2010, Bitcoin grew from practically nothing to an almost$1-trillion asset, and counting. This could be even bigger. Nice Video at weisscryptoalert.com

Read More
Relief Reports 2020 Financial Results and Provides Business Update
Apr16

Relief Reports 2020 Financial Results and Provides Business Update

GENEVA, SWITZERLAND / ACCESSWIRE / April 15, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat COVID-19 induced lung injury, today announced its 2020 financial results for the year ended December 31, 2020 and provided a business update. “The past year...

Read More
RELIEF CONFIRMS RELEASE OF 60-DAY Findings
Apr13

RELIEF CONFIRMS RELEASE OF 60-DAY Findings

RELIEF CONFIRMS RELEASE OF 60-DAY FINDINGS FROM PHASE 2B/3 CLINICAL TRIAL OF INTRAVENOUS RLF-100™ (AVIPTADIL) 30 March 2021 60-day results have been presented by Relief’s partner, NeuroRx, Inc. Geneva, Switzerland, March 30, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief”), a biopharmaceutical company with its lead compound RLF-100™ (aviptadil) in advanced clinical development to treat critically-ill COVID-19...

Read More
NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19
Mar03

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint NeuroRx to File for Emergency Use Authorization in This Patient Population if Positive Results Continue to be Demonstrated at Day-60 Endpoint in Line with FDA’s New Guidance NEWS PROVIDED BY NeuroRx ...

Read More
Cryptocurrency Ethereum hits record high
Feb23

Cryptocurrency Ethereum hits record high

Cryptocurrency Ethereum hits record high, lifted by bitcoin, institutional demand By Gertrude Chavez-Dreyfuss NEW YORK (Reuters) – Ethereum, the second largest cryptocurrency in terms of market capitalization and volume, hit a record high on Thursday, lifted by growing institutional interest in the space, and more than a week after its futures were launched on the Chicago Mercantile Exchange. The virtual currency reached an...

Read More
Bitcoin ETF Roars in Debut With $165 Million of Trading Volume
Feb23

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume (Bloomberg) — North America’s first Bitcoin ETF got off to a stellar start in its debut, with investors exchanging $165 million worth of shares. After a relentless surge in the world’s largest digital currency, the first Bitcoin product that’s officially labeled an exchange-traded fund debuted Thursday in Toronto. It’s worth noting, though, that Europe has several...

Read More

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume

Bitcoin ETF Roars in Debut With $165 Million of Trading Volume   (Bloomberg) — North America’s first Bitcoin ETF got off to a stellar start in its debut, with investors exchanging $165 million worth of shares. After a relentless surge in the world’s largest digital currency, the first Bitcoin product that’s officially labeled an exchange-traded fund debuted Thursday in Toronto. It’s worth noting, though, that Europe has...

Read More
NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™
Feb09

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™

NeuroRx and Relief Therapeutics Report Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ in Reducing Hospital Stay Among Patients with Respiratory Failure due to Critical COVID-19 If Authorized for Use, ZYESAMI™ Would be First Treatment Specifically for Critically Ill Patients with Respiratory Failure RADNOR, Pa. and GENEVA, Feb. 9, 2021 /PRNewswire/ — NeuroRx, Inc. and Relief Therapeutics Holdings...

Read More
RELIEF AFFIRMS INITIATION OF PHASE 2/3
Feb09

RELIEF AFFIRMS INITIATION OF PHASE 2/3

RELIEF AFFIRMS INITIATION OF PHASE 2/3 TRIAL OF INHALED RLF-100™ (AVIPTADIL; ZYESAMI™) IN SEVERE COVID-19 PATIENTS 08 February 2021 Top-line data from intravenous RLF-100™ phase 2b/3 trial expected to be released this month Geneva, Switzerland, February 08, 2021 – RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) (“Relief” or the “Company”) affirms that its collaboration partner NeuroRx, Inc. has...

Read More
Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments
Feb08

Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments

Tesla Invests $1.5 Billion in Bitcoin, Plans to Accept BTC Payments Tesla has purchased $1.5 billion of Bitcoin, according to a 10-K filed with the Securities and Exchange Commission (SEC), which was first reported by Crowdfund Insider. The massive Bitcoin investment by the electric vehicle maker prompted the cryptocurrency’s price to jump 7 percent, taking it past $43,000 for the first time in its history. Under the SEC filing,...

Read More
Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM
Jan25

Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM

Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM 1:20 am ET January 21, 2021 (Accesswire) Print GENEVA, SWITZERLAND / ACCESSWIRE / January 21, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF) (“Relief” or the “Company”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19...

Read More
Relief and AdVita Sign Binding to Acquire All Shares of AdVita
Jan25

Relief and AdVita Sign Binding to Acquire All Shares of AdVita

Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Mergers & Acquisitions 20.01.2021 / 07:00 Relief and AdVita Sign Binding Term Sheet for Relief to Acquire All Shares of AdVita to Expand Scope of Development of Inhaled Formulation of Aviptadil Geneva, Switzerland, and...

Read More